An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH.
- Published In:
- Journal of hepatology, 79(2), 552-566 (2023)
- Authors:
- Tacke, Frank, Puengel, Tobias, Loomba, Rohit(5), Friedman, Scott L
- Database ID:
- RPEP-07442
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07442APA
Tacke, Frank; Puengel, Tobias; Loomba, Rohit; Friedman, Scott L. (2023). An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH.. Journal of hepatology, 79(2), 552-566. https://doi.org/10.1016/j.jhep.2023.03.038
MLA
Tacke, Frank, et al. "An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH.." Journal of hepatology, 2023. https://doi.org/10.1016/j.jhep.2023.03.038
RethinkPeptides
RethinkPeptides Research Database. "An integrated view of anti-inflammatory and antifibrotic tar..." RPEP-07442. Retrieved from https://rethinkpeptides.com/research/tacke-2023-an-integrated-view-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.